GT BIOPHARMA, INC. Operating Leases, Future Minimum Payments, Due in Two Years
GT BIOPHARMA, INC. (GTBP) had Operating Leases, Future Minimum Payments, Due in Two Years of $61.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-11-13
- 2020-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $61.00K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $61.00K.
- 2020-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $61.00K.
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $61.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2020-09-30 | $61.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $61.00K 10-Q/A · filed 2020-08-18 |
| 2020-03-31 | $61.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $61.00K 10-K · filed 2020-03-27 |
| 2018-12-31 | $71.00K 10-K · filed 2019-03-29 |
| 2017-12-31 | $108.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |